Buy Immune Pharmaceuticals Stock | IMNP Stock Price & Latest News | Public.com
IMNP

Immune Pharmaceuticals

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Immune Pharmaceuticals (IMNP) stock trends here

    About IMNP

    Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eos...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$2,45M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$0.06
    1 Year Low$0.00
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app